Signet Financial Management, LLC Mirati Therapeutics, Inc. Transaction History

Signet Financial Management, LLC

  • $778 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$32.0 - $47.43 $61,920 - $91,777
-1,935 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$47.1 - $62.7 $74,182 - $98,752
1,575 Added 437.5%
1,935 $91,000
Q1 2018

May 15, 2018
BUY
$17.2 - $34.95 $6,192 - $12,582
360 New
360 $11,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Signet Financial Management, LLC Portfolio

Follow Signet Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email